rs1060499969
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_000455.5(STK11):c.1037_1042delGCGCGG(p.Gly346_Ala347del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00000186 in 1,610,832 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000455.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.1037_1042delGCGCGG | p.Gly346_Ala347del | disruptive_inframe_deletion | Exon 8 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.1037_1042delGCGCGG | p.Gly346_Ala347del | disruptive_inframe_deletion | Exon 8 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.2304_2309delGCGCGG | non_coding_transcript_exon_variant | Exon 9 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.1037_1042delGCGCGG | p.Gly346_Ala347del | disruptive_inframe_deletion | Exon 8 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.1037_1042delGCGCGG | p.Gly346_Ala347del | disruptive_inframe_deletion | Exon 8 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.665_670delGCGCGG | p.Gly222_Ala223del | disruptive_inframe_deletion | Exon 10 of 12 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000411 AC: 1AN: 243400Hom.: 0 AF XY: 0.00000754 AC XY: 1AN XY: 132654
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458686Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 725416
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74306
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:3
- -
This variant, c.1037_1042del, results in the deletion of 2 amino acid(s) of the STK11 protein (p.Gly346_Ala347del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with STK11-related conditions. ClinVar contains an entry for this variant (Variation ID: 403793). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The STK11 c.1037_1042del; p.Gly346_Ala347del change deletes six nucleotides at position 1037-1042 resulting in an in-frame deletion of two amino acids in exon 8. This change has a maximum subpopulation frequency of 0.00091% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). This variant has been reported in at least one individual with a personal and/or family history of breast or ovarian cancers who underwent multi-gene panel testing for hereditary breast and ovarian cancer risk assessment (PMID: 31742824). One individual with this variant is reported in a database of women older than 70 years of age who have never had cancer (FLOSSIES, https://whi.color.com/). To our knowledge, this variant has not been reported in individuals with Peutz-Jeghers syndrome. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Hereditary cancer-predisposing syndrome Uncertain:2
- -
The c.1037_1042delGCGCGG variant (also known as p.G346_A347del) is located in coding exon 8 of the STK11 gene. This variant results from an in-frame GCGCGG deletion at nucleotide positions 1037 to 1042. This results in the in-frame deletion of a glycine and an alanine residue at codons 346 to 347. This variant was identified in a cohort of 882 Chinese individuals with a personal and/or family history of breast or ovarian cancers who underwent multi-gene panel testing for HBOC risk assessment (Shao D et al. Cancer Sci, 2020 Feb;111:647-657). This amino acid region is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Uncertain:1
- -
Melanoma, cutaneous malignant, susceptibility to, 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at